ImpactAlpha, Sept. 11 – Vancouver-based Terramera’s Series B was led by two ag-focused funders: new investor Ospraie Ag Science and returning investor Seed2Growth (“S2G”) Ventures.
Terramera says its Actigate Targeted Performance technology increases the performance of natural and synthetic ingredients by delivering them directly into target cells, reducing the levels of chemicals needed and boosting the performance of natural agents.
The funding will help the nine-year old firm deliver on its ambitious goal of cutting global synthetic chemical loads by 80% while increasing global farm productivity and yields by 20%, according to Jeff Booth, who is assuming the role of chairman.